contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


kalqyl-eql-pharma-vd-intervju-med-axel-schorling-om-de-senaste-leveransforseningarna

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

EQL Pharma operates in the pharmaceutical industry and focuses on the development, manufacturing and distribution of generic medicines. The company's products are aimed at healthcare institutions and patients who need cost-effective treatment options. The business is global with a primary presence in Europe, North America and Asia. EQL Pharma was founded in 2006 and is headquartered in Lund, Sweden.

EQL Pharma

Vi har intervjuat EQL Pharmas VD Axel Schörling om de senaste leveransförseningarna. Vi diskuterar de bakomliggande orsakerna till de aktuella problemen, effekterna på tillväxt och marginaler...

<div class="mfn-preamble"><p><strong>Vi har intervjuat EQL Pharmas VD Axel Schörling om de senaste leveransförseningarna. Vi diskuterar de bakomliggande orsakerna till de aktuella problemen, effekterna på tillväxt och marginaler, samt hur bolaget avser att navigera genom en period av osäkerhet. Vi pratar även om femårsplanen som fortsatt ligger fast, samt bolagets plan och de största uppsidorna för att nå målen.</strong></p></div><div class="mfn-body"><p><a rel="noopener" href="https://youtu.be/2d3L6k7pf74">Se hela intervjun här</a></p></div><div class="mfn-footer mfn-contacts mfn-8721526a862f"><p><strong class="mfn-heading-1">För mer information, vänligen kontakta:</strong></p><hr><p><strong>Albin Eriksson</strong>, analytiker (albin@kalqyl.se) <br><strong>Erik Lundberg</strong>, analytiker (erik.lundberg@kalqyl.se)<br><strong>Pontus Fredriksson</strong>, analytiker (pontus@kalqyl.se)</p></div><div class="mfn-footer mfn-about mfn-46a74da06bb8"><p><strong class="mfn-heading-1">Om Kalqyl</strong></p><hr><p>Kalqyl är ett nytänkande analysbolag med en snabbväxande plattform och en unik räckvidd bland nordiska investerare. Med djup expertis och fokus på kvalitativt innehåll levererar vi analyser och intervjuer som engagerar och skapar värde.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Bifogade filer</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/cf8b2ae8-d00b-40f3-8bf6-e9ece58b66c4/eql-pharma-vd-intervju-med-axel-schorling-om-de-senaste-leveransforseningarna.pdf" class="mfn-generated mfn-primary">EQL Pharma: VD-intervju med Axel Schörling om de senaste leveransförseningarna</a></p></div>

Kalqyl: EQL Pharma: VD-intervju med Axel Schörling om de senaste leveransförseningarna